ArrowMark Colorado Holdings’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
ArrowMark Colorado Holdings's DFTX Position: Q3 2026 in Review
ArrowMark Colorado Holdings reduced its Definium Therapeutics (DFTX) stake by 17% in Q3 2026, selling an estimated $3.97M and leaving 469,831 shares worth $17.9M. The position accounts for 0.85% of the portfolio, ranked #19.
ArrowMark Colorado Holdings first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $30.1M in Q1 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- ArrowMark Colorado Holdings held 469,831 shares of Definium Therapeutics worth $17.9M as of Q3 2026.
- ArrowMark Colorado Holdings sold 94,238 Definium Therapeutics shares in Q3 2026, an estimated $3.97M.
- Definium Therapeutics made up 0.85% of ArrowMark Colorado Holdings's portfolio in Q3 2026, its #19 holding.
- ArrowMark Colorado Holdings first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
- ArrowMark Colorado Holdings's Definium Therapeutics position peaked at $30.1M in Q1 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on ArrowMark Colorado Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.